The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS ...
Beta blockers as monotherapy or first-line therapy were evaluated in a Cochrane review of 13 randomized trials with a total of 91,561 adults (Cochrane Database Syst Rev. 2007;[1]:CD002003) and were ...
London, United Kingdom – 30 August 2024: The cardiovascular safety of interrupting beta-blocker could not be shown in comparison to continuation in patients with a history of myocardial infarction (MI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results